Launch of Insilico Medicine's AI and Quantum Computing R&D Center in Abu Dhabi
Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East
01 févr. 2023 09h27 HE | InSilico Medicine
Abu Dhabi, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine ("Insilico"), a clinical-stage artificial intelligence (AI)-driven drug discovery company, is announcing today the opening of the...
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
10 janv. 2023 09h00 HE | InSilico Medicine
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of...
A Next Generation Lab
Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery
05 janv. 2023 09h00 HE | InSilico Medicine
New York, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life...
Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A for ER+/HER2- Breast Cancer Therapy with End-to-End AI Engine
27 déc. 2022 12h30 HE | InSilico Medicine
New York, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company's...
Insilico Medicine Nominates Potential First-in-Class Preclinical Candidate with Novel AI-Designed Structure for Novel AI-Discovered Target in Immuno-oncology
20 déc. 2022 09h00 HE | InSilico Medicine
New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company...
Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases and cancer using AI
01 déc. 2022 09h00 HE | InSilico Medicine
New York, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced...
Insilico Medicine at 41st Annual J.P. Morgan Healthcare Conference
Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting
29 nov. 2022 09h00 HE | InSilico Medicine
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the  41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI
23 nov. 2022 09h00 HE | InSilico Medicine
New York, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, is designing new non-hormonal contraceptive...
Advancing AI Drug Discovery
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
08 nov. 2022 09h00 HE | InSilico Medicine
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Advancing AI Drug Discovery
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
08 nov. 2022 09h00 HE | InSilico Medicine
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...